GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Sale Of Property, Plant, Equipment

Australian Clinical Labs (ASX:ACL) Sale Of Property, Plant, Equipment : A$0.1 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs Sale Of Property, Plant, Equipment?

Australian Clinical Labs's sale of property, plant, equipment for the six months ended in Dec. 2024 was A$0.1 Mil. It means Australian Clinical Labs gained A$0.1 Mil from selling property, plant, and equipment. Australian Clinical Labs's sale of property, plant, equipment for the trailing twelve months (TTM) ended in Dec. 2024 was A$0.1 Mil.

Compared with last quarter (A$0.1 Mil in Jun. 2024 ), Australian Clinical Labs gained more money from selling property, plant, and equipment in Dec. 2024 (A$0.1 Mil).

Australian Clinical Labs Sale Of Property, Plant, Equipment Historical Data

The historical data trend for Australian Clinical Labs's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australian Clinical Labs Sale Of Property, Plant, Equipment Chart

Australian Clinical Labs Annual Data
Trend Dec20 Jun21 Jun22 Jun23 Jun24
Sale Of Property, Plant, Equipment
- 0.11 0.27 0.24 0.33

Australian Clinical Labs Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Sale Of Property, Plant, Equipment Get a 7-Day Free Trial Premium Member Only 0.09 0.15 0.27 0.06 0.07

Australian Clinical Labs Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.

Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Australian Clinical Labs Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Australian Clinical Labs's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

Australian Clinical Labs Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Sale Of Property, Plant, Equipment
Comparable Companies
ASX:MVF ASX:IDX ASX:HLS ASX:GSS ASX:MAP ASX:IIQ ASX:CTE ASX:BDX ASX:RHY ASX:IBX TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD WAT NTRA
Traded in Other Exchanges
N/A
Address
1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168
Website
https://www.clinicallabs.com.au
Australian Clinical Labs is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well established in the states of Western Australia, South Australia, Victoria, and the Northern Territory.

Australian Clinical Labs Headlines

No Headlines